Ken Griffin Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Citadel Advisors LLC holds 3,000 shares of XPH stock, worth $120,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,000

Previous 2,400 25.0%

Holding current value

$120,540

Previous $103,000 27.18%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$42.3 - $45.81 $1.68 Million - $1.82 Million	-39,683 Reduced 90.57%	4,130 $180,000
Q4 2024 Feb 14, 2025	BUY	$42.71 - $48.29 $845,145 - $955,562	19,788 Added 82.36%	43,813 $1.88 Million
Q3 2024 Nov 14, 2024	BUY	$39.24 - $45.31 $939,248 - $1.08 Million	23,936 Added 26894.38%	24,025 $1.07 Million
Q2 2024 Aug 14, 2024	SELL	$39.09 - $42.64 $1.01 Million - $1.1 Million	-25,813 Reduced 99.66%	89 $3,000
Q1 2024 May 15, 2024	BUY	$41.38 - $45.49 $1.05 Million - $1.15 Million	25,334 Added 4460.21%	25,902 $1.12 Million
Q4 2023 Feb 14, 2024	SELL	$35.2 - $41.92 $938,291 - $1.12 Million	-26,656 Reduced 97.91%	568 $23,000
Q3 2023 Nov 14, 2023	SELL	$39.75 - $44.12 $505,540 - $561,118	-12,718 Reduced 31.84%	27,224 $1.08 Million
Q2 2023 Aug 14, 2023	SELL	$39.1 - $42.57 $241,481 - $262,912	-6,176 Reduced 13.39%	39,942 $1.64 Million
Q1 2023 May 15, 2023	BUY	$39.61 - $44.25 $1.76 Million - $1.96 Million	44,314 Added 2456.43%	46,118 $1.89 Million
Q4 2022 Feb 14, 2023	BUY	$40.06 - $43.59 $72,268 - $78,636	1,804 New	1,804 $73,000
Q4 2021 Feb 14, 2022	BUY	$43.72 - $52.45 $464,350 - $557,071	10,621 Added 62.56%	27,599 $0
Q3 2021 Nov 15, 2021	SELL	$46.51 - $53.1 $562,631 - $642,350	-12,097 Reduced 41.61%	16,978 $805,000
Q2 2021 Aug 16, 2021	BUY	$48.16 - $53.09 $698,223 - $769,698	14,498 Added 99.46%	29,075 $0
Q1 2021 May 17, 2021	BUY	$49.44 - $56.01 $720,686 - $816,457	14,577 New	14,577 $734,000
Q4 2020 Feb 16, 2021	SELL	$43.42 - $52.06 $635,451 - $761,898	-14,635 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$42.46 - $45.34 $621,402 - $663,550	14,635 New	14,635 $636,000
Q2 2020 Aug 14, 2020	SELL	$34.56 - $44.18 $986,549 - $1.26 Million	-28,546 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.56 - $47.91 $408,386 - $619,955	-12,940 Reduced 31.19%	28,546 $1.03 Million
Q4 2019 Feb 14, 2020	BUY	$34.65 - $46.53 $263,166 - $353,395	7,595 Added 22.41%	41,486 $1.9 Million
Q3 2019 Nov 14, 2019	BUY	$35.59 - $37.64 $575,561 - $608,714	16,172 Added 91.27%	33,891 $0
Q2 2019 Aug 14, 2019	BUY	N/A	2,440 Added 15.97%	17,719 $706,000
Q4 2018 Feb 14, 2019	SELL	N/A	-26,934 Reduced 63.8%	15,279 $0
Q2 2018 Aug 10, 2018	BUY	N/A	9,672 Added 29.72%	42,213 $0
Q1 2018 May 11, 2018	BUY	N/A	9,810 Added 43.16%	32,541 $1.36 Million
Q4 2017 Feb 09, 2018	SELL	N/A	-4,366 Reduced 16.11%	22,731 $989,000
Q3 2017 Nov 09, 2017	BUY	N/A	27,097	27,097 $1.15 Million

Others Institutions Holding XPH

# of Institutions

Shares Held

2.9M

Call Options Held

13K

Put Options Held

26.1K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account